Report Detail
Global Combination Vaccines for Children Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4589127 |
- 21 May, 2024 |
- Global |
- 105 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
According to our (Global Info Research) latest study, the global Combination Vaccines for Children market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The Combination Vaccines for Children Market is experiencing a growing trend, with major sales regions including North America, Europe, and Asia Pacific. The market is witnessing a high concentration of key players offering a wide range of combination vaccines for children, which is driving market growth. There are significant opportunities in the market, such as increasing awareness about the importance of vaccination, government initiatives to promote immunization programs, and advancements in vaccine technology. However, the market also faces challenges such as stringent regulatory requirements, high costs associated with vaccine development, and vaccine hesitancy among some parents. Overall, the Combination Vaccines for Children Market is poised for continued growth in the coming years.
This report is a detailed and comprehensive analysis for global Combination Vaccines for Children market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Combination Vaccines for Children market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Combination Vaccines for Children market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Combination Vaccines for Children market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Combination Vaccines for Children market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Combination Vaccines for Children
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Combination Vaccines for Children market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline (GSK), Merck（Sanofi）, Mitsubishi Tanabe Pharma, KM Biologics, Walvax Biotechnology, Biokangtai, Sinovac, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Combination Vaccines for Children market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
DTaP
MMR
Others
Market segment by Application
Hospital
Clinic
Other
Major players covered
GlaxoSmithKline (GSK)
Merck（Sanofi）
Mitsubishi Tanabe Pharma
KM Biologics
Walvax Biotechnology
Biokangtai
Sinovac
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Combination Vaccines for Children product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Combination Vaccines for Children, with price, sales quantity, revenue, and global market share of Combination Vaccines for Children from 2019 to 2024.
Chapter 3, the Combination Vaccines for Children competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Combination Vaccines for Children breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Combination Vaccines for Children market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Combination Vaccines for Children.
Chapter 14 and 15, to describe Combination Vaccines for Children sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Combination Vaccines for Children Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 DTaP
- 1.3.3 MMR
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Combination Vaccines for Children Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Combination Vaccines for Children Market Size & Forecast
- 1.5.1 Global Combination Vaccines for Children Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Combination Vaccines for Children Sales Quantity (2019-2030)
- 1.5.3 Global Combination Vaccines for Children Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 GlaxoSmithKline (GSK)
- 2.1.1 GlaxoSmithKline (GSK) Details
- 2.1.2 GlaxoSmithKline (GSK) Major Business
- 2.1.3 GlaxoSmithKline (GSK) Combination Vaccines for Children Product and Services
- 2.1.4 GlaxoSmithKline (GSK) Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
- 2.2 Merck（Sanofi）
- 2.2.1 Merck（Sanofi） Details
- 2.2.2 Merck（Sanofi） Major Business
- 2.2.3 Merck（Sanofi） Combination Vaccines for Children Product and Services
- 2.2.4 Merck（Sanofi） Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Merck（Sanofi） Recent Developments/Updates
- 2.3 Mitsubishi Tanabe Pharma
- 2.3.1 Mitsubishi Tanabe Pharma Details
- 2.3.2 Mitsubishi Tanabe Pharma Major Business
- 2.3.3 Mitsubishi Tanabe Pharma Combination Vaccines for Children Product and Services
- 2.3.4 Mitsubishi Tanabe Pharma Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
- 2.4 KM Biologics
- 2.4.1 KM Biologics Details
- 2.4.2 KM Biologics Major Business
- 2.4.3 KM Biologics Combination Vaccines for Children Product and Services
- 2.4.4 KM Biologics Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 KM Biologics Recent Developments/Updates
- 2.5 Walvax Biotechnology
- 2.5.1 Walvax Biotechnology Details
- 2.5.2 Walvax Biotechnology Major Business
- 2.5.3 Walvax Biotechnology Combination Vaccines for Children Product and Services
- 2.5.4 Walvax Biotechnology Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Walvax Biotechnology Recent Developments/Updates
- 2.6 Biokangtai
- 2.6.1 Biokangtai Details
- 2.6.2 Biokangtai Major Business
- 2.6.3 Biokangtai Combination Vaccines for Children Product and Services
- 2.6.4 Biokangtai Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Biokangtai Recent Developments/Updates
- 2.7 Sinovac
- 2.7.1 Sinovac Details
- 2.7.2 Sinovac Major Business
- 2.7.3 Sinovac Combination Vaccines for Children Product and Services
- 2.7.4 Sinovac Combination Vaccines for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Sinovac Recent Developments/Updates
3 Competitive Environment: Combination Vaccines for Children by Manufacturer
- 3.1 Global Combination Vaccines for Children Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Combination Vaccines for Children Revenue by Manufacturer (2019-2024)
- 3.3 Global Combination Vaccines for Children Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Combination Vaccines for Children by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Combination Vaccines for Children Manufacturer Market Share in 2023
- 3.4.3 Top 6 Combination Vaccines for Children Manufacturer Market Share in 2023
- 3.5 Combination Vaccines for Children Market: Overall Company Footprint Analysis
- 3.5.1 Combination Vaccines for Children Market: Region Footprint
- 3.5.2 Combination Vaccines for Children Market: Company Product Type Footprint
- 3.5.3 Combination Vaccines for Children Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Combination Vaccines for Children Market Size by Region
- 4.1.1 Global Combination Vaccines for Children Sales Quantity by Region (2019-2030)
- 4.1.2 Global Combination Vaccines for Children Consumption Value by Region (2019-2030)
- 4.1.3 Global Combination Vaccines for Children Average Price by Region (2019-2030)
- 4.2 North America Combination Vaccines for Children Consumption Value (2019-2030)
- 4.3 Europe Combination Vaccines for Children Consumption Value (2019-2030)
- 4.4 Asia-Pacific Combination Vaccines for Children Consumption Value (2019-2030)
- 4.5 South America Combination Vaccines for Children Consumption Value (2019-2030)
- 4.6 Middle East & Africa Combination Vaccines for Children Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 5.2 Global Combination Vaccines for Children Consumption Value by Type (2019-2030)
- 5.3 Global Combination Vaccines for Children Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 6.2 Global Combination Vaccines for Children Consumption Value by Application (2019-2030)
- 6.3 Global Combination Vaccines for Children Average Price by Application (2019-2030)
7 North America
- 7.1 North America Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 7.2 North America Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 7.3 North America Combination Vaccines for Children Market Size by Country
- 7.3.1 North America Combination Vaccines for Children Sales Quantity by Country (2019-2030)
- 7.3.2 North America Combination Vaccines for Children Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 8.2 Europe Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 8.3 Europe Combination Vaccines for Children Market Size by Country
- 8.3.1 Europe Combination Vaccines for Children Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Combination Vaccines for Children Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Combination Vaccines for Children Market Size by Region
- 9.3.1 Asia-Pacific Combination Vaccines for Children Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Combination Vaccines for Children Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 10.2 South America Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 10.3 South America Combination Vaccines for Children Market Size by Country
- 10.3.1 South America Combination Vaccines for Children Sales Quantity by Country (2019-2030)
- 10.3.2 South America Combination Vaccines for Children Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Combination Vaccines for Children Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Combination Vaccines for Children Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Combination Vaccines for Children Market Size by Country
- 11.3.1 Middle East & Africa Combination Vaccines for Children Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Combination Vaccines for Children Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Combination Vaccines for Children Market Drivers
- 12.2 Combination Vaccines for Children Market Restraints
- 12.3 Combination Vaccines for Children Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Combination Vaccines for Children and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Combination Vaccines for Children
- 13.3 Combination Vaccines for Children Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Combination Vaccines for Children Typical Distributors
- 14.3 Combination Vaccines for Children Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Combination Vaccines for Children. Industry analysis & Market Report on Combination Vaccines for Children is a syndicated market report, published as Global Combination Vaccines for Children Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Combination Vaccines for Children market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
